Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Samii

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
Chemico-Biological Interactions|March 27, 2010
Human PON1, a biomarker of risk of disease and exposureC E Furlong, S M Suzuki, R C Stevens, et al.
Brain : a Journal of Neurology|August 20, 2009
Longitudinal progression of sporadic Parkinson's disease: a multi-tracer positron emission tomography studyR Nandhagopal, L Kuramoto, M Schulzer, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 8, 2001
Transdermal dopaminergic D(2) receptor agonist therapy in Parkinson's disease with N-0923 TDS: a double-blind, placebo-controlled studyJ T Hutton, L V Metman, T N Chase, et al.
Neurology|September 30, 2010
A comprehensive analysis of deletions, multiplications, and copy number variations in PARK2D M Kay, C F Stevens, T H Hamza, et al.
Neurology|March 14, 2008
Lrrk2 R1441C parkinsonism is clinically similar to sporadic Parkinson diseaseK Haugarvoll, R Rademakers, J M Kachergus, et al.
The New England Journal of Medicine|October 23, 2009
Multicenter analysis of glucocerebrosidase mutations in Parkinson's diseaseE Sidransky, M A Nalls, J O Aasly, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
Chemico-Biological Interactions|March 27, 2010
Human PON1, a biomarker of risk of disease and exposureC E Furlong, S M Suzuki, R C Stevens, et al.
Brain : a Journal of Neurology|August 20, 2009
Longitudinal progression of sporadic Parkinson's disease: a multi-tracer positron emission tomography studyR Nandhagopal, L Kuramoto, M Schulzer, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 8, 2001
Transdermal dopaminergic D(2) receptor agonist therapy in Parkinson's disease with N-0923 TDS: a double-blind, placebo-controlled studyJ T Hutton, L V Metman, T N Chase, et al.
Neurology|September 30, 2010
A comprehensive analysis of deletions, multiplications, and copy number variations in PARK2D M Kay, C F Stevens, T H Hamza, et al.
Neurology|March 14, 2008
Lrrk2 R1441C parkinsonism is clinically similar to sporadic Parkinson diseaseK Haugarvoll, R Rademakers, J M Kachergus, et al.
The New England Journal of Medicine|October 23, 2009
Multicenter analysis of glucocerebrosidase mutations in Parkinson's diseaseE Sidransky, M A Nalls, J O Aasly, et al.
Pageof 7